Merck & Co. Available for sale investments increased by 371.3% to $476.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 31.0%, from $690.00M to $476.00M. Over 5 years (FY 2020 to FY 2025), Available for sale investments shows an upward trend with a 2.6% CAGR.
An increase suggests higher liquidity and potential for capital gains, while a decrease may indicate asset liquidation or market value depreciation.
This represents the fair value of debt securities that are not classified as held-to-maturity or trading. These assets a...
Standard across insurance and banking sectors as part of the investment portfolio.
other_available_for_sale_securities_debt_securities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $88.00M | $89.00M | $86.00M | $454.00M | $412.00M | $76.00M | $569.00M | $760.00M | $821.00M | $247.00M | $337.00M | $117.00M | $127.00M | $81.00M | $536.00M | $690.00M | $707.00M | $145.00M | $101.00M | $476.00M |
| QoQ Change | — | +1.1% | -3.4% | +427.9% | -9.3% | -81.6% | +648.7% | +33.6% | +8.0% | -69.9% | +36.4% | -65.3% | +8.5% | -36.2% | +561.7% | +28.7% | +2.5% | -79.5% | -30.3% | +371.3% |
| YoY Change | — | — | — | — | +368.2% | -14.6% | +561.6% | +67.4% | +99.3% | +225.0% | -40.8% | -84.6% | -84.5% | -67.2% | +59.1% | +489.7% | +456.7% | +79.0% | -81.2% | -31.0% |